Treatment of Advanced Squamous Cell Carcinoma of the Skin with Isotretinoin
Authors:
- 1 October 1987
- journal article
- research article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 107 (4) , 499-501
Abstract
To determine the efficacy of oral isotretinoin in refractory advanced squamous cell carcinoma of the skin. Case series trial. Tertiary care center at a university hospital. A consecutive collection of four patients with advanced squamous cell carcinoma of the skin who failed to respond to standard surgical or radiation therapy. Isotretinoin in gelatin capsules was given at a total daily dose of 1 mg/kg body weight in two divided doses for at least 4 weeks. Bidimensional tumor measurements at monthly intervals showed striking responses to isotretinoin in all four patients. Response durations ranged from 2 to more than 23 months. The drug produced reversible moderate mucocutaneous side effects and asymptomatic laboratory abnormalities. Impressive responses to isotretinoin occurred in our four patients and in six of ten other reported patients. Retinoic acid's mechanisms of action in cutaneous squamous cell carcinoma is not precisely known, but may involve the modulation of epidermal growth factor receptors and certain protein kinases. These in-vitro findings and the clinical data suggest that retinoids may be an effective and well-tolerated therapy for refractory advanced squamous cell carcinoma of the skin. The absence of any other effective systemic therapy indicates the need for continuing trials with retinoids in this disease.Keywords
This publication has 17 references indexed in Scilit:
- Basal Cell Carcinoma and Squamous Cell Carcinoma: Recognition and TreatmentMedical Clinics of North America, 1986
- Variant of A431 cells isolated by ricin A-conjugated monoclonal antibody directed to EGF receptor: Phosphorylation of EGF receptor and phosphatidylinositolSomatic Cell and Molecular Genetics, 1985
- Treatment of perineural metastasis from squamous carcinoma of the skin with aggressive combination chemotherapy and irradiationJournal of Surgical Oncology, 1985
- Cisplatin and doxorubicin. An effective chemotherapy combination in the treatment of advanced basal cell and squamous carcinoma of the skinCancer, 1985
- Oral Isotretinoin TherapyArchives of Dermatology, 1984
- The effects of a novel potent oral retinoid (Ro13-6298) in the treatment of multiple solar keratoses and squamous cell epitheliomaEuropean Journal of Cancer and Clinical Oncology, 1983
- TREATMENT OF CUTANEOUS T-CELL LYMPHOMA (MYCOSIS FUNGOIDES) WITH 13-CIS-RETINOIC ACIDThe Lancet, 1983
- ETRETINATE IN TREATMENT OF ACTINIC KERATOSISThe Lancet, 1982
- Retinoids, Cancer, and the SkinArchives of Dermatology, 1981
- Metastases in Dermatological Patients With Squamous Cell CarcinomaArchives of Dermatology, 1979